Menetrier's disease therapy: rebooting mucosal signaling.
Where this comes from
- Record sourced from PubMed, PMID 20368184.
- Also identified by DOI 10.1126/scitranslmed.3000438.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Ménétrier's disease, a rare hyperproliferative disorder of the stomach, is associated with chronic abdominal pain, vomiting, weight loss, and edema, as well as an increased risk of gastric cancer. Therapy, other than surgical resection of the stomach, is limited to supportive measures and reflects the limited understanding of Ménétrier's disease pathogenesis. Data reported in this issue describe a promising targeted therapeutic approach and provide new insight into the causes of Ménétrier's disease.
Medical subject headings
- Gastric Mucosa
- Gastritis, Hypertrophic
- Signal Transduction